The irradiation biology of the brown marmorated stink bug (BMSB, Halyomorpha halys Stål) treated at the nymphal stage was investigated to determine its application for sterile insect technique (SIT). Fifth instar males of BMSB were exposed to gamma-radiation 60Co at different doses of 12, 16, 20, 24 and 64 Gy. Irradiated males were mated with non-irradiated virgin females to assess the longevity of both sexes, female fecundity and fertility of their offspring until the egg stage of the F2 generation. The mortality of each of the developmental stages of the F1 and eggs of the F2 generation was observed to determine whether negative effects from exposure to radiation was inherited. The data indicated that irradiation significantly reduced the lifespan of male insects at doses above 20Gy. Irradiated males did not affect the longevity and fecundity of their female partners, nor either sex of their resulting progeny, but it did reduce the hatch rate of the eggs at all doses tested. The sterility rates of F1 eggs were 55.6%, 73.3%, 74.1% and 74.1% at doses of 12Gy, 16Gy, 20Gy and 24Gy respectively. Eggs were completely sterile (100%) at a dose of 64Gy with no egg hatch recorded. A low hatch rate of F2 eggs illustrated that negative effects from radiation was inherited by the subsequent generation. The results support the potential for the use of SIT for BMSB management by irradiating the fifth instar male nymphs at 16-64Gy.

Pheidole oxyops Forel, 1908 is a generalist ant, which forages actively for plant debris to dead arthropods. In addition, its nest has an entrance that allows the ants gather resources passively by capturing falling preys into the nest. Our objective was to verify if different day periods, temperature and residual soil accumulation (ground pile in the side of nest entrance) could influence the patterns of foraging activity. Foraging activities were registered in the morning, afternoon and twilight. We measured direction and vector of trails, air temperature and humidity during foraging events. Our results showed that foraging routes are independent of residual soil accumulation and other nearby nests. However, air temperature and the time daily period are significant factors to foragers’ exits. Higher air temperatures influenced negatively the exits. In the period of the afternoon, the ants do not show any preference for routes, different from the morning and twilight. In addition, foraging activities were significantly more frequent during twilight period. Leaving the nest at twilight could allow ants foraging in an environment with less exposition to potential predators and competitors. Moreover, it may be also related to opportunism to hunt other nocturnal insects.

Allergic diseases represent a global health and economic burden of increasing significance. The lack of disease-modifying therapies besides specific allergen immunotherapy (AIT) which is not available for all types of allergies, necessitates the study of novel therapeutic approaches. Exosomes are small endosome-derived vesicles delivering cargo between cells and thus allowing inter-cellular communication. Since immune cells make use of exosomes to boost, deviate, or suppress immune responses, exosomes are intriguing candidates for immunotherapy. Here, we review the role of exosomes in allergic sensitization and inflammation and we discuss the mechanisms by which exosomes could be used in immunotherapeutic approaches for the treatment of allergic diseases. We propose the following approaches: a) Mast cell derived exosomes expressing IgE receptor FcεRI could absorb IgE and down-regulate systemic IgE levels. b) Tolerogenic exosomes could suppress allergic immune responses via induction of regulatory T cells. c) Exosomes could promote TH1-like responses towards an allergen. d) Exosomes could modulate IgE-facilitated antigen presentation.

Currently, SARS-CoV-2 infection which is the causative agent for COVID-19 disease is a worldwide pandemic with more than 100 million global cases and more than 2.0 million deaths (as of January, 2021). While several vaccines for prevention of COVID-19 have already been registered by the regulatory authorities, the problem is that the substitution rate of this virus is estimated to be one change per 2 weeks, thus mutations could arise that threaten the efficacy of vaccines. Unfortunately, there is no current evidence from random clinical trials to recommend any specific post-exposure treatment for patients with suspected or confirmed COVID-19 disease. Here we propose an innovative superinfection therapeutic (SIT) strategy, which could complement the development of prophylactic vaccines. SIT is based on clinical observations that unrelated harmless viruses might interact in patients infected with pathogenic virus. During SIT, the patient benefits from superinfection with an apathogenic double-stranded RNA (dsRNA) virus such as the infectious bursal disease virus (IBDV), which is a powerful activator of the interferon-dependent antiviral gene program. An attenuated vaccine strain of IBDV was already successfully administered to resolve acute and persistent infections induced by two completely different viruses, the hepatitis B (DNA) and C (RNA) viruses (HBV/HCV). The safety of orally administered acid-resistant IBDV strain R903/78 reverse engineered viral drug candidate was demonstrated in 10 stage IV cancer patients who exhausted all conventional therapy. Following repeated oral administration of the virus up to 10⁹ infectious units (IU)/ dose, only mild flu-like side effects were reported in some patients. Proof-of-principle efficacy was demonstrated in an early COVID-19 patient who was successfully treated with 3x10⁶ IU of an attenuated IBDV vaccine. A small scale dose-finding Phase I safety study is proposed.